Loading company…
Toregem Biopharma develops treatments intended to promote tooth growth in patients with congenital tooth loss.
Founded in 2020 and based in Kyoto, Japan, Toregem Biopharma develops treatments for congenital tooth loss and other dental conditions. In May 2026, it raised JPY 850 million in pre-Series C funding from OSAKA University Venture Capital, SIIF Impact Capital, Chushin Venture Capital, Bi Holdings Co., Ltd., SHOFU INC. and JIC Venture Growth Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in